Expediting rare disease diagnosis: a call to bridge the gap between clinical and functional genomics
Open Access
- 25 November 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Molecular Medicine
- Vol. 26 (1), 1-7
- https://doi.org/10.1186/s10020-020-00244-5
Abstract
Approximately 400 million people throughout the world suffer from a rare disease. Although advances in whole exome and whole genome sequencing have greatly facilitated rare disease diagnosis, overall diagnostic rates remain below 50%. Furthermore, in cases where accurate diagnosis is achieved the process requires an average of 4.8 years. Reducing the time required for disease diagnosis is among the most critical needs of patients impacted by a rare disease. In this perspective we describe current challenges associated with rare disease diagnosis and discuss several cutting-edge functional genomic screening technologies that have the potential to rapidly accelerate the process of distinguishing pathogenic variants that lead to disease.This publication has 37 references indexed in Scilit:
- The mutational constraint spectrum quantified from variation in 141,456 humansNature, 2020
- Identification of functional regulatory elements in the human genome using pooled CRISPR screensBMC Genomics, 2020
- Predictable and precise template-free CRISPR editing of pathogenic variantsNature, 2018
- Pathogenic variants that alter protein code often disrupt splicingNature Genetics, 2017
- Direct Identification of Hundreds of Expression-Modulating Variants using a Multiplexed Reporter AssayCell, 2016
- Enhanced utility of family-centered diagnostic exome sequencing with inheritance model–based analysis: results from 500 unselected families with undiagnosed genetic conditionsGenetics in Medicine, 2015
- Genome-Scale CRISPR-Cas9 Knockout Screening in Human CellsScience, 2014
- Mutations in TUBG1, DYNC1H1, KIF5C and KIF2A cause malformations of cortical development and microcephalyNature Genetics, 2013
- Systematic dissection of regulatory motifs in 2000 predicted human enhancers using a massively parallel reporter assayGenome Research, 2013
- Nescient Helix-Loop-Helix 2 Interacts with Signal Transducer and Activator of Transcription 3 to Regulate Transcription of Prohormone Convertase 1/3Molecular Endocrinology, 2008